Table 8. Prevalence of indications, success, and complication rates of TLE.
Year of publication | Number of patients with leads extracted | Number of leads extracted | Number of patients with infection indication / % | Number of patients with non-infection indication / % | Clinical success rate | Procedure success rate | Major complication number / (%) | Minor complication number / (%) | |
Tułecki et al. (2021) [19] | 2021 | 1500 | 230 (15.33%) | 1,270 (84.6%) | 98.93% | 96.13% | 33 (2.20%) | 115 (7.67%) | |
Monsefi et al. (2019) [3] | 2018 | 108 | 277 | 79 (73.1%) | 27 (26.9%) | 98% | 98.7% | 15 | |
Mkoko et al. (2021) [4] | 2021 | 53 | 75 | 69.2% | 30.8% | 96.2% | 84.6% | 1 (1.9%) | 1(1.9%) |
Aleong et al. (2020) [13] | 2020 | 8304 | 57220 | 9,196 (16.1%) | 34,240 (59.8%) | 3,298 (5.8%) | |||
Chung et al. (2022) [20] | 2022 | 510 | 1181 | 387 (75.9%) | 123 (24.1%) | 496 (97.1%) | 471 (92.4%) | 9 (1.80%) | 9 (1.80%) |